• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

风湿性心脏病:复杂免疫事件介导的疾病。

Rheumatic heart disease: mediation by complex immune events.

机构信息

Heart Institute (InCor), School of Medicine, University of São Paulo, São Paulo, Brazil.

出版信息

Adv Clin Chem. 2011;53:31-50.

PMID:21404913
Abstract

Rheumatic fever (RF) is an autoimmune disease caused by the Gram-positive bacteria Streptococcus pyogenes following an untreated throat infection in susceptible children. Rheumatic heart disease (RHD), the most serious complication, occurs in 30-45% of RF patients and leads to chronic valvular lesions. Here, we focus on the genes that confer susceptibility for developing this disease. Molecular mimicry mediates the cross-reactions between streptococcal antigens and human proteins. Several autoantigens have been identified, including cardiac myosin epitopes, vimentin, and other intracellular proteins. In heart tissue, antigen-driven oligoclonal T cell expansions probably cause the rheumatic heart lesions. These cells are CD4+ and produce inflammatory cytokines (TNF alpha and IFN gamma). IL-4+ cells are found in the myocardium; however, these cells are very scarce in the valve lesions of RHD patients. IL-4 is a Th2-type cytokine and plays a regulatory role in the inflammatory response mediated by Th1 cytokines. Our findings indicate that the Th1/Th2 cytokine balance has a role in healing myocarditis while the low numbers of IL-4-producing cells in the valves probably induced the progressive and permanent valve damage.

摘要

风湿热(RF)是一种自身免疫性疾病,由未经治疗的链球菌咽峡炎后,革兰阳性细菌酿脓链球菌引起。风湿性心脏病(RHD)是最严重的并发症,发生于 30-45%的 RF 患者,导致慢性瓣膜病变。在这里,我们重点关注易患该病的基因。分子模拟介导链球菌抗原和人蛋白之间的交叉反应。已经鉴定出几种自身抗原,包括心肌肌球蛋白表位、波形蛋白和其他细胞内蛋白。在心脏组织中,抗原驱动的寡克隆 T 细胞扩增可能导致风湿性心脏病变。这些细胞是 CD4+,并产生炎症细胞因子(TNFα和 IFNγ)。在心肌中可以发现 IL-4+细胞;然而,在 RHD 患者的瓣膜病变中,这些细胞非常罕见。IL-4 是一种 Th2 型细胞因子,在 Th1 细胞因子介导的炎症反应中发挥调节作用。我们的研究结果表明,Th1/Th2 细胞因子平衡在心肌炎愈合中起作用,而瓣膜中产生 IL-4 的细胞数量较少可能导致进行性和永久性瓣膜损伤。

相似文献

1
Rheumatic heart disease: mediation by complex immune events.风湿性心脏病:复杂免疫事件介导的疾病。
Adv Clin Chem. 2011;53:31-50.
2
Rheumatic fever: how S. pyogenes-primed peripheral T cells trigger heart valve lesions.风湿热:化脓性链球菌致敏的外周T细胞如何引发心脏瓣膜病变。
Ann N Y Acad Sci. 2005 Jun;1051:132-40. doi: 10.1196/annals.1361.054.
3
Pathology and pathogenesis of rheumatic heart disease.风湿性心脏病的病理学与发病机制
Indian J Pathol Microbiol. 2007 Oct;50(4):685-97.
4
Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease.风湿热和风湿性心脏病:导致自身免疫反应和疾病的细胞机制。
J Clin Immunol. 2010 Jan;30(1):17-23. doi: 10.1007/s10875-009-9332-6. Epub 2009 Oct 3.
5
Rheumatic fever and rheumatic heart disease: genetics and pathogenesis.风湿热与风湿性心脏病:遗传学与发病机制
Scand J Immunol. 2007 Aug-Sep;66(2-3):199-207. doi: 10.1111/j.1365-3083.2007.01974.x.
6
Rheumatic fever: from innate to acquired immune response.风湿热:从先天性免疫反应到获得性免疫反应
Ann N Y Acad Sci. 2007 Jun;1107:426-33. doi: 10.1196/annals.1381.045.
7
Molecular pathogenesis of rheumatic fever and rheumatic heart disease.风湿热和风湿性心脏病的分子发病机制。
Expert Rev Mol Med. 2005 Dec 8;7(28):1-15. doi: 10.1017/S146239940501015X.
8
PDIA3, HSPA5 and vimentin, proteins identified by 2-DE in the valvular tissue, are the target antigens of peripheral and heart infiltrating T cells from chronic rheumatic heart disease patients.在瓣膜组织中通过双向电泳鉴定出的蛋白质PDIA3、HSPA5和波形蛋白,是慢性风湿性心脏病患者外周血和心脏浸润T细胞的靶抗原。
J Autoimmun. 2008 Sep;31(2):136-41. doi: 10.1016/j.jaut.2008.04.023. Epub 2008 Jun 9.
9
How an autoimmune reaction triggered by molecular mimicry between streptococcal M protein and cardiac tissue proteins leads to heart lesions in rheumatic heart disease.由链球菌M蛋白与心脏组织蛋白之间的分子模拟引发的自身免疫反应如何导致风湿性心脏病中的心脏病变。
J Autoimmun. 2005 Mar;24(2):101-9. doi: 10.1016/j.jaut.2005.01.007.
10
Heart-directed autoimmunity: the case of rheumatic fever.心脏定向自身免疫:以风湿热为例。
J Autoimmun. 2001 May;16(3):363-7. doi: 10.1006/jaut.2000.0487.

引用本文的文献

1
Effect of Dapagliflozin on Patients with Rheumatic Heart Disease Mitral Stenosis.达格列净对风湿性心脏病二尖瓣狭窄患者的影响。
J Clin Med. 2023 Sep 11;12(18):5898. doi: 10.3390/jcm12185898.
2
Repairing the rheumatic mitral valve in the young: The horizon revisited.为年轻患者修复风湿性二尖瓣:重探前景。
JTCVS Open. 2020 Mar 6;1:20-28. doi: 10.1016/j.xjon.2020.02.006. eCollection 2020 Mar.
3
Recent Advances in the Rheumatic Fever and Rheumatic Heart Disease Continuum.风湿热和风湿性心脏病连续体的最新进展
Pathogens. 2022 Jan 28;11(2):179. doi: 10.3390/pathogens11020179.
4
Histopathological Characterization of Mitral Valvular Lesions from Patients with Rheumatic Heart Disease.风湿性心脏病患者二尖瓣病变的组织病理学特征。
Arq Bras Cardiol. 2021 Mar;116(3):404-412. doi: 10.36660/abc.20200154.
5
Mechanistic implications of altered protein expression in rheumatic heart disease.风湿性心脏病中蛋白质表达改变的机制意义。
Heart Fail Rev. 2022 Jan;27(1):357-368. doi: 10.1007/s10741-020-09993-1.
6
Synergistic Activation of Toll-Like and NOD Receptors by Complementary Antigens as Facilitators of Autoimmune Disease: Review, Model and Novel Predictions.协同激活 Toll 样受体和 NOD 受体的互补抗原作为自身免疫病的促进剂:综述、模型和新预测。
Int J Mol Sci. 2020 Jun 30;21(13):4645. doi: 10.3390/ijms21134645.
7
Interleukin 4: Its Role in Hypertension, Atherosclerosis, Valvular, and Nonvalvular Cardiovascular Diseases.白细胞介素4:其在高血压、动脉粥样硬化、瓣膜性和非瓣膜性心血管疾病中的作用
J Cardiovasc Pharmacol Ther. 2020 Jan;25(1):7-14. doi: 10.1177/1074248419868699. Epub 2019 Aug 11.
8
Mitral Valve Pathology.二尖瓣病变。
Curr Cardiol Rep. 2019 May 23;21(7):61. doi: 10.1007/s11886-019-1145-5.
9
Association of ficolin-2 (FCN2) functional polymorphisms and protein levels with rheumatic fever and rheumatic heart disease: relationship with cardiac function.纤维胶凝蛋白-2(FCN2)功能多态性及蛋白水平与风湿热和风湿性心脏病的关联:与心功能的关系
Arch Med Sci Atheroscler Dis. 2018 Dec 15;3:e142-e155. doi: 10.5114/amsad.2018.80999. eCollection 2018.
10
Thrombocytopenia as a Preoperative Risk Assessment Tool in Patients With Rheumatic Heart Disease Undergoing Valve Replacement Surgery.血小板减少症作为风湿性心脏病患者瓣膜置换术前的风险评估工具。
J Am Heart Assoc. 2017 Dec 4;6(12):e006988. doi: 10.1161/JAHA.117.006988.